Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China
· Delayed Price · Currency is CNY 11.85
+0.05 (0.42%)
At close: Jun 23, 2025, 2:57 PM CST
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 26.69 billion as of June 27, 2025. Its market cap has decreased by -12.64% in one year.
Market Cap
26.69B
Enterprise Value
26.98B
Revenue
5.53B
Ranking
n/a
PE Ratio
19.95
Stock Price
11.85
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has increased from 22.34B to 26.69B, an increase of 19.49%. That is a compound annual growth rate of 7.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 26.58B | 0.64% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 346.07B |
| Shenzhen Mindray Bio-Medical Electronics | 271.92B |
| WuXi AppTec | 192.14B |
| Zhangzhou Pientzehuang Pharmaceutical., | 120.94B |
| Sichuan Biokin Pharmaceutical | 117.61B |
| Aier Eye Hospital Group | 113.87B |
| Shanghai United Imaging Healthcare | 104.54B |
| Yunnan Baiyao Group Co.,Ltd | 98.85B |